Benzinga’s Top Ratings Upgrades, Downgrades For June 15, 2023
Upgrades For OGE Energy Corp (NYSE:OGE), Ladenburg Thalmann upgraded the previous rating of Neutral to Buy. In the…
Expert Ratings for Cullinan Oncology
Cullinan Oncology (NASDAQ:CGEM) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
4 Analysts Have This to Say About Cullinan Oncology
Within the last quarter, Cullinan Oncology (NASDAQ:CGEM) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…
A Look Into Healthcare Sector Value Stocks
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are…
Cullinan Oncology To Present First Clinical Data Evaluating Novel Anti-MICA/B Antibody, CLN-619, In Patients With Advanced Solid Tumors At ASCO 2023
Cullinan Oncology, Inc. (NASDAQ:CGEM), a biopharmaceutical company focused on modality-agnostic targeted oncology therapies, today announced that the first clinical data from its Phase 1 clinical study of
Overview Of Value Stocks In The Healthcare Sector
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the…
What 4 Analyst Ratings Have To Say About Cullinan Oncology
Analysts have provided the following ratings for Cullinan Oncology (NASDAQ:CGEM) within the last quarter: Bullish Somewhat Bullish Indifferent…
HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Maintains $50 Price Target
HC Wainwright & Co. analyst Edward White reiterates Cullinan Oncology (NASDAQ:CGEM) with a Buy and maintains $50 price target.
Cullinan Oncology Licenses U.S. Rights To The First Clinical-Stage B7H4 x 4-1BB Bispecific Immune Activator From Harbour BioMed; Currently In A Phase 1 Clinical Study Being Conducted At U.s. And Australian Sites In Patients With Advanced Solid Tumors
Cullinan Oncology, Inc. (NASDAQ:CGEM) and Harbour BioMed (HKEX: 02142) today announced that Cullinan Oncology has entered into an exclusive license with Harbour BioMed for the development and
5 Value Stocks In The Healthcare Sector
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of…